It announced in 2019 that it would expand into a second center for gene therapy production, for a 150,000-square-foot building that it's calling ASTRA. Krystal Biotech names new chief commercial ...
PITTSBURGH, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal” or the "Company") (NASDAQ: KRYS), the leader in redosable gene therapy, today reported financial results and key ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback